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BACKGROUND. Missed papillary thyroid carcinoma (PTC) diagnoses on fine-nee-
dle aspiration (FNA) can result from many causes. To the authors’ knowledge,
the issue of whether the detection of PTC is correlated with nodule heterogeneity
has not been studied to date.
METHODS. The authors identified all thyroidectomy specimens with a diagnosis
of PTC that had undergone at least 1 prior FNA in the study institution between
1998 and 2003. The tumor size at the time of the resection, the ultrasound (US)-
determined nodule size, and other parameters were compared between the 2
groups in which PTC was or was not diagnosed on FNA.
RESULTS. Of a total of 89 specimens, 47 were diagnosed on FNA with an average
tumor size of 1.7 cm and an US-determined nodule size of 2.1 cm (a difference
of 0.4 cm). Forty-two specimens with a smaller average tumor size of 0.9 cm
(P \ .0001) and a US-determined nodule size of 2.4 cm (a difference of 1.5 cm)
were missed. The differences with regard to the US-determined nodule size and
tumor size between the 2 groups were significant (0.4 cm vs 1.5 cm; P\.0001).
In the missed group, 29 specimens were found to have PTC foci that measured
1.0 cm and 26 had a reasonable size difference (RSD; defined as a PTC size out-
side the range of 50% of the US-determined nodule size) as the indicator of the
mixed nature of nodules targeted for FNA, whereas in the diagnostic group, 9
foci measured 1.0 cm and 6 had RSD. There was no cytologic evidence with
which to render a diagnosis of PTC on further review in the missed group.
CONCLUSIONS. The major reason for a missed diagnosis of PTC on FNA is
because of inadequate tumor sampling due to the heterogeneity of the nodule
targeted for FNA. This is illustrated by the RSD noted between the targeted nod-
ule and the actual PTC tumor focus in the resection specimen. Cancer (Cancer
Cytopathol) 2008;114:27–33.  2007 American Cancer Society.
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P apillary thyroid carcinomas (PTC) represent 75% to 80% of allmalignant thyroid neoplasms.1 Increasing sensitivities of various
diagnostic modalities, including ultrasound (US)guided-fine-needle
aspiration (FNA) has made it possible to detect even the smallest of
lesions. Papillary thyroid microcarcinoma (PTMC) is defined by the
World Health Organization (WHO) as those PTC that measure 1.0
cm in greatest dimension and are found incidentally.1 To our knowl-
edge, the biology of PTMC is not well understood, but several
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studies have demonstrated that a certain subset can
behave aggressively, demonstrating capsular invasion
and lymph node metastasis.2–4 As a result, PTMCs
should be followed and treated as classic PTC.2–4 In
patients who present with a thyroid nodule, US-
guided FNA is the procedure of choice to initially
characterize the lesion. It is relatively fast, cost-effec-
tive, and minimally invasive. FNA has a reported sen-
sitivity of 65% to 95% and a specificity of 70% to
100%.5 Discrepancies between thyroid FNA and the
surgical resection diagnosis can be due to several
reasons, including inadequate material for evalua-
tion, nonrepresentative sampling, and ambiguous
cytologic features. To our knowledge, the issue of
whether the detection of PTC is correlated with nod-
ule heterogeneity has not been studied to date.
Herein, we analyzed the size difference between the
targeted nodules and PTC foci on thyroidectomy spe-
cimens as an indicator of nodule heterogeneity to
address whether this affected the diagnostic accuracy
of FNA.
MATERIALS AND METHODS
A computer search for all thyroidectomy specimens
that had a diagnosis of PTC from 1998 through 2003
was performed at the University of Michigan Hospi-
tal (Ann Arbor, Mich). Only those resections that had
at least 1 prior FNA were included in the current
study. Several characteristics of both the FNA and
resection specimens were noted, including exact FNA
diagnosis, whether the aspirate was attended by a
pathologist to assess adequacy, size of the tumor,
whether frozen section was performed at the time of
resection and, if it was, whether the frozen section
was positive. For the cases in which PTC was not
diagnosed or suspected on FNA but was subse-
quently diagnosed by resection, we reviewed both
the FNA and resection slides to determine the reason
for the discrepancy. In addition, we determined the
size of the US-targeted nodule by reviewing the US
and/or clinic report.
At the study institution, the majority of thyroid
aspirations are performed by clinicians and are not
always attended by a pathologist. During the above
time frame, the majority of aspirations were per-
formed by a radiologist/endocrinologist with US gui-
dance. When a pathologist was not requested to
attend the aspiration, the aspirated material was sub-
mitted entirely into CytoLyt (Cytyc Corporation, Box-
borough, Mass). This was then centrifuged and
resuspended in PreservCyt solution (Cytyc Corpora-
tion) and from this, a ThinPrep (Cytyc Corporation)
slide was generated according to the manufacturer’s
directions. In addition, a cell block was also made.
When a pathologist was requested to assess ade-
quacy, onsite air-dried slides stained with Diff-Quik
(Dade Behring, Newark, Del) were made as well as
alcohol-fixed slides for Papanicolaou staining; both
were referred to as conventional smears (CS). A Thin-
Prep slide (TP) was also made from the needle rinse
and occasionally an additional cell block slide (CB)
was created when there was sufficient material.
The correlation between the size of the PTC at
the time of resection and the diagnostic ability of
FNA was explored using standard logistic regression.
The log odds of a PTC diagnosis were modeled with
PTC size separately as a continuous covariate and as
indicators for size categories. The size cutpoints for
categories were chosen based on expert opinion, the
WHO definition of PTMC, and the observed pattern
of the diagnostic ability of FNA by millimeter size
intervals in our cohort. The odds ratio and the prob-
ability of a correct diagnosis for each size category
were calculated. When comparing covariates between
groups (diagnostic vs missed), the Student 2-tailed
t test and chi-square statistic were used for continu-
ous and categoric data, respectively. For all statistical
tests, P values 5% were considered significant.
RESULTS
A total of 107 FNA specimens with a histologic diag-
nosis of PTC, regardless of tumor size, were identi-
fied during the 6-year period. Thirteen patients
underwent 2 FNAs before thyroidectomy; only the
last FNA was used in the final analysis so the thy-
roidectomy was correlated with only 1 FNA. Five
patients had PTC foci that were histologically docu-
mented as ‘‘multifocal.’’ On US, these individual
nodules were found to range from 1.5 cm to 6.0 cm.
For the summary of tumor size, these 5 ‘‘multifocal’’
cases were excluded, resulting in a cohort of 89
cases; however, for statistical modeling purposes,
these 5 cases were considered to be in the largest
size group (therefore, N 5 94). The female-to-male
ratio was 3:1 and the average age of the patients was
43.9 years (41.6 years in women and 51.5 years in
men). Forty-seven of the 89 cases were diagnosed as
PTC or suspicious for PTC on FNA (sensitivity of
53%) with concordance at resection (diagnostic
group). The remaining 42 cases were not diagnosed
as PTC on FNA but were found to contain a PTC
focus at the time of resection (missed group). Over-
all, 38 FNAs resulted in resections that demonstrated
PTC foci that measured 1.0 cm. Of these, 29 (76%)
were missed by FNA. Table 1 summarizes the charac-
teristics of the 2 groups. Finally, 4 cases had a cystic
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PTC that measured [1.0 cm (2 cases had a PTC that
measured 3.0 cm) at the time of resection; only 1
was diagnosed as ‘‘possibly cystic PTC’’ on FNA and
the others were considered ‘‘cystic content.’’
In the diagnostic group, the size of the nodules
targeted by US imaging for FNA averaged 2.1 cm
(range, 0.8–5.0 cm). On resection, the average PTC
size in the diagnostic group was found to be 1.7 cm.
The absolute difference between the US size and the
resection size was 0.409 cm, a difference that was
statistically significant (P 5 .0005). Thirty-eight thy-
roidectomy specimens had a tumor size [1.0 cm
whereas 9 specimens had a tumor size of 1.0 cm.
Comparing the cytologic features of tumor cells from
the aspirates of both large ([1.0 cm) and small (1.0
cm) nodules, no definitive differences could be
appreciated. In the diagnostic group, 6 patients had
undergone 2 prior FNAs. The findings of the first
FNA in this 6-case set were nondiagnostic (3 cases),
multinodular hyperplasia (1 case), lymphocytic thy-
roiditis (1 case), and atypical follicular epithelium
(1 case), whereas the second (repeat) FNA did reveal
PTC in all 6 patients. Thirty-two of the total 47 FNAs
(68%) in the diagnostic group were performed with a
pathologist assessing adequacy, resulting in an aver-
age of 5 passes per procedure and cytologic evalua-
tion on CS and TP (and CB) slides. Of these 32 cases,
9 (28%) were diagnosed as suspicious for PTC. Con-
versely, of 15 cases not attended by a pathologist
(resulting in morphology evaluation on TP and CB
slides only), 9 (60%) were termed suspicious for PTC.
In the diagnostic group, 10 cases had frozen sections
performed; 6 were correctly diagnosed as PTC. The 4
missed cases were the result of interpretation diffi-
culties encountered on frozen section because 1 was
the follicular variant of PTC, another was the scleros-
ing variant of PTC, and 2 had a background of florid
lymphocytic (Hashimoto) thyroiditis.
In the missed group, the size of the nodules tar-
geted by US for FNA averaged 2.4 cm (range, 0.6–5.0
cm), a finding that was not statistically significantly
different from the diagnostic groups (P 5 .1912). At
resection, the average PTC size in this group was
found to be 0.9 cm, which is much smaller than that
of the diagnostic group (1.7 cm) (P \.0001). The dif-
ference between the US size and the resection size
was 1.451 cm, a difference that also was statistically
significant (P \ .0001). Thirteen cases had a tumor
size [1.0 cm and the remaining 29 cases measured
1.0 cm. In this group, 7 patients had undergone 2
prior FNAs. Neither of the FNAs was diagnostic of or
suspicious for PTC and was termed nondiagnostic (1
case), atypical follicular cells (1 case), Hurthle cell
neoplasm (1 case), nodular hyperplasia (2 cases),
and follicular lesions (2 cases) in both aspirates. Sim-
ilar to the diagnostic group, 26 of the total 42 FNAs
(62%) in the missed group were performed with a
pathologist assessing adequacy, resulting in an aver-
age of 6 passes per procedure. Fourteen cases had
frozen sections performed; 7 were correctly diag-
nosed as PTC, only 2 of which measured 1.0 cm.
All 7 cases that were missed on frozen section had
small PTC foci, most of which measured \0.5 cm,
with a background of large, multinodular goiter
nodules making them difficult to identify. Table 2
summarizes the FNA diagnoses in the missed group.
Further cytologic review of these cases confirmed the
original diagnoses, which included nodular hyperpla-
sia, lymphocytic thyroiditis, and follicular cell lesion,
and there were no cytologic features to suggest a di-
agnosis of PTC.
To better evaluate whether the heterogeneous
nature of the nodule, as indicated by the size differ-
ence between FNA US-targeted thyroid nodules and
actual PTC foci, contributed to the missed PTC diag-
TABLE 1





ALL No. 47 FNAs 42 FNAs
Average tumor size (range), cm 1.7 (0.6–4.0)*,y 0.9 (0.05–3.5)*,{
Pathologist assessing adequacy 32 26
Average no. of passes 5 6
Frozen section performed 10 14
Confirmed PTC? 6 7
Multifocal 3 2
Double FNAs 6 7
Reasonable size difference 6 26
Average US nodule size, cm 2.1y 2.4{
1.0 cm No. 9 29
Average tumor size (range), cm 0.9 (0.6–1.0) 0.4 (0.05–1.0)
Pathologist assessing adequacy 7 20
Average no. of passes 5 6
Frozen section performed 4 7
Confirmed PTC? 2 2
Double FNAs 1 4
Reasonable size difference 0 25
[1.0 cm No. 38 13
Average tumor size (range), cm 1.9 (1.1–4.0) 2.2 (1.2–3.5)
Pathologist assessing adequacy 25 6
Average no. of passes 5 5
Frozen section performed 6 7
Confirmed PTC? 4 5
Double FNAs 5 3
Reasonable size difference 6 1
FNA indicates fine-needle aspiration; PTC, papillary thyroid carcinoma; US, ultrasound.
* Diagnostic group vs nondiagnostic group: P\.0001.
y Average tumor size vs average US nodule size (diagnostic group): P 5 .0005.
{ Average tumor size vs average US nodule size (missed group): P\.0001.
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nosis on FNA, we arbitrarily defined ‘‘reasonable size
difference’’ (RSD) as the PTC focus in the resection
specimen being outside of  50% of the US-deter-
mined or clinically determined nodule size. For
example, an FNA was diagnosed as nodular hyper-
plasia and at resection demonstrated a PTC focus
measuring 0.1 cm; the US size of the target nodule
was 3.1 cm. According to the above definition, this is
an RSD. Of the 42 specimens in the missed group, 26
(62%) fell within our definition of RSD, essentially
meaning that the FNA-targeted nodule was heteroge-
neous in nature and much larger than the PTC focus
identified at the time of resection (Fig. 1). Of these
26 specimens, 25 demonstrated PTC foci that meas-
ured 1.0 cm. For the remaining 16 specimens in
which there was no RSD, 6 were inadequate and the
remaining cases were interpreted as Hurthle cell
lesions (2 cases), follicular lesions (3 cases), nodular
hyperplasia (4 cases), or Hashimoto thyroiditis (1
case). If the RSD nodules and inadequate FNAs from
the missed group are not considered, then the diag-
nostic sensitivity increases to 82% from 53%. Of the
47 specimens in the diagnostic group, only 6 (13%)
had an RSD whereas the remaining 41 specimens did
not (Fig. 2). For 9 PTCs in the diagnostic group
measuring \1.0 cm, no RSD was demonstrated.
Furthermore, when comparing the differences
between the average tumor size at resection and the
average US-determined nodule size between the
missed group (1.451 cm) and diagnostic group (0.409
cm), the difference was also statistically significant
(P \ .0001) (ie, there was a difference between the
differences).
When examining the actual proportion of correct
diagnoses by tumor size interval using all 94 FNA
specimens, there appeared to be a steady increase in
the proportion of correctly diagnosed FNAs, then a
plateau, and then a decrease as the size became[2.5
cm (Fig. 3). Visually, there appeared to be break-
points at 1.0 cm and 2.5 cm. The odds of a correct
PTC diagnosis using these breakpoints separate the
tumor size into 3 groups: 1.0 cm, 1.0 cm to 2.5 cm,
and 2.5 cm. If we use the group of tumors meas-
uring 1.0 cm to 2.5 cm as a reference, the odds of an
incorrect diagnosis are increased 12 times (odds ratio
[OR] of 12.0; 95% confidence interval [95% CI], 4.2 –
34.4 [P \ .0001]) for smaller tumors and are
increased 4 times (OR of 4.1; 95% CI, 1.1–15.2
[P 5 .0329]) for larger tumors. A statistical model
with the tumor size divided into groups of 1 cm,
1.0 cm to 2.5 cm, and 2.5 cm demonstrates the
probability of a correct FNA diagnosis of PTC at
19.51%, 78.57%, and 50%, respectively.
TABLE 2
Distribution of the FNA Diagnosis in The Missed Group
Multinodular hyperplasia 21
Hashimoto thyroiditis 3
Hurthle cell neoplasm 2
Hurthle cell lesion 1
Follicular neoplasm 1
Rare atypical cells 1
Nondiagnostic 13
Total 42
FNA indicates fine–needle aspiration.
FIGURE 1. Comparison of ultrasound (US)-determined nodule size (open triangle) with 50% range and tumor size at the time of resection (filled diamond)
for each thyroidectomy specimen in the fine-needle aspiration missed group (the x axis lists each case, numbered N1N42).
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DISCUSSION
The use of highly sensitive US-guided FNA of the
thyroid has greatly enhanced our ability to detect
and diagnose thyroid pathology without the need for
more invasive procedures. However, a recent publica-
tion demonstrated that the concordance in nodules
measured by US and surgical pathology examination
is 50% in the majority of cases.6 When US-guided
FNA is employed for nonpalpable thyroid nodules
(1.0 cm), most institutions report adequate aspira-
tions.7 The characterization of thyroid nodules by US
is possible and routinely performed. Features such as
microcalcifications, irregular surgical margins, and
marked hypoechogenicity suggest malignancy and
warrant an FNA.8 In addition, nodules that are clini-
cally worrisome demonstrate rapid growth, contain a
dominant nodule among uniformly smaller nodules,
have concurrent palpable or sonographically docu-
mented abnormal cervical lymph nodes, or are recur-
rent cystic nodules.9 Even with these clinical and
sonographic features, it is still possible to not ade-
quately sample a small PTC focus. Specifically, if the
targeted nodule is relatively large and heterogeneous
with non-PTC components, the small PTC focus may
not be sampled, even with an ‘‘adequately sampled
specimen.’’ Our goal herein was to determine
whether the heterogenetic nature of the nodule con-
tributes to missing the diagnosis of PTC, including
PTMC, on an FNA when the resection does indeed
contain PTC.
In the current study, we demonstrated that, on
resection, PTCs in the FNA diagnostic group were
significantly larger than in the FNA missed group
(1.7 cm vs 0.9 cm; P \ .0001). We further demon-
strated that the US-targeted nodules were larger than
the eventual PTC foci in both the diagnostic and
missed groups but were more significant in the
missed groups (size difference of 0.4 cm vs 1.5 cm;
P \ .0001). Because there was a significant size dis-
crepancy between the targeted nodules and the
actual tumor foci, indicative of the heterogeneous
nature of the target nodule, the missed PTC diagno-
FIGURE 2. Comparison of ultrasound (US)-determined nodule size (open triangle) with 50% range and tumor size at the time of resection (filled diamond)
for each thyroidectomy specimen in the fine-needle aspiration diagnosed group (the x axis lists each case, numbered N1N47).
FIGURE 3. Actual percentage of correctly diagnosed cases plotted at the
midpoint of 2-millimeter intervals for the size of the final resected tumor.
The frequency of cases was indicated for each interval. FNA indicates fine-
needle aspiration; PTC, papillary thyroid carcinoma.
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sis was most likely due to inadequate sampling of tu-
mor cells on FNA because no features of PTC were
noted on those FNA specimens. Therefore, they were
missed not because of interpretation error but
because tumor cells were not sampled, although
most specimens were deemed adequate for evalua-
tion. The average number of passes and onsite eva-
luation did not appear to have any noticeable impact
on the ability to make the diagnosis of PTC because
there was no difference noted between the diagnostic
and missed groups with regard to these aspects.
Although FNA operator experience has been demon-
strated to affect diagnostic yield by others,10 we did
not address this issue in the current study. We con-
sidered it not to be a major factor affecting the FNA
diagnosis because at the study institution, the major-
ity of cases were performed or supervised by an
experienced endocrinologist or radiologist; we
regarded all of them to be at a similar experience
level.
In the missed group, 26 of 42 nodules were
within our definition of RSD. In other words, the
PTC focus in the resection specimen and the target
nodule in the US study were significantly different
with regard to their sizes, which is indicative of the
heterogeneous nature of the targeted nodules. In
striking contrast, 87% of the specimens in the diag-
nostic group (100% of those with a PTC focus 1.0
cm) demonstrated no RSD and therefore the target
nodule at FNA and the PTC focus identified at the
time of resection are presumed to be one and the
same. The correlation between the mixed nature of
the nodule and PTC diagnostic accuracy is made
even clearer because 25 of 26 nodules in the missed
group measured 1.0 cm (PTMC). Because nodules
measuring \1.0 cm on US are often not being sub-
jected to FNA, PTMC would often be found in target
nodules measuring [1.0 cm, thus generating poten-
tial RSD and no sampling of the tumor on FNA. This
would result in a low diagnostic yield on FNA, which
is supported by our statistical model as shown in
Figure 3, with a 19.51% probability of diagnosing
PTC when the PTC foci measures \1.0 cm. When
PTCs are in the range of 1.0 cm through 2.5 cm, a
much better diagnostic yield (78.57%) is achieved
because those nodules appear to be more homoge-
neous, with a similar size in the targeted nodule and
the tumor.
PTMC, for the most part, is clinically insignifi-
cant because it has been found in approximately
33% of autopsy or unexpected surgical cases.3 How-
ever, there is a small percentage of these that do
behave more aggressively and demonstrate capsular
invasion and lymph node metastasis.1,3 Distinguish-
ing PTMC from ordinary PTC on FNA is virtually
impossible. Perez et al. described 8 cases of thyroid
FNAs that were suspicious for PTC and were found
on histologic examination to be PTMC.11 On histolo-
gic examination, each of these specimens contained
a focus of PTMC ranging from 0.1 cm to 0.4 cm that
was adjacent to the larger non-PTC nodules that
were targeted for FNA. In our study, the average size
of PTC foci in the missed (false-negative) group was
0.9 cm and, overall, 38 patients had PTC that by defi-
nition was PTMC. We considered this to be the main
reason why, in our cohort, the sensitivity of the FNA
diagnosis of PTC is lower than that in the literature.5
When we examined frozen sections performed on
thyroidectomy specimens based on tumor size (Table
1), tumors that measured 1.0 cm were more likely
to be missed because small PTC foci were masked by
the background of larger benign nodules/lesions.
This brings credence to the notion that the mixed
nature of the nodule is an important factor in the
false-negative diagnosis of PTC on FNA.
In a College of American Pathology Laboratory
Improvement Program, those FNA specimens that
lacked marked nuclear enlargement, chromatin
clearing, and intranuclear inclusions were more likely
to be misdiagnosed as something other than PTC.12
Cases that performed well included those that had
the typical features of PTC. In the current study, the
cases in the missed group did not have features that
would have raised the suspicion for PTC. Therefore,
misinterpretation was not the reason a diagnosis was
not made.
Although the TP has demonstrated diagnostic
sensitivity and specificity similar to those of CS,13,14
Michael and Hunter have shown potential pitfalls
that are unique to this process.15 In our study,
although the TP-only and CB-only specimens in the
diagnostic or missed groups were similar, not gener-
ating bias for diagnosis, the above mentioned pitfalls
were noted. In the diagnostic group, those pitfalls
might also have contributed to a diagnosis of ‘‘suspi-
cious for PTC’’ in 9 of 15 cases (60%) evaluated with
TP and CB only, a finding that is much higher than
that of cases with onsite assessment and evaluated
by a combination of CS and TP and/or CB (28%).
Therefore, it is logical to conclude that the combina-
tion of the onsite adequacy assessment and cytologic
evaluation CS reduced the number of cases with
a suspicious diagnosis, although the current study
was not designed to compare these 2 preparation
methods.
Cystic masses pose an additional diagnostic chal-
lenge that has been well documented.16,17,18 Cystic
masses contribute to interpretation errors with
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‘‘atypical’’ cells.16 In addition, a cystic mass also gen-
erates RSD, an indicator of nodule heterogeneity, thus
affecting tumor sampling. In Figure 3, at the 2.5-cm
cutoff point, there was a counterintuitive decrease in
the probability of a correct diagnosis to 50%. This is
in part because of the finding that 2 cases in this
group were diagnosed as ‘‘cyst contents’’ on FNA but
subsequently were found to demonstrate cystic PTC
(3.0 cm) at the time of surgical resection because
thyroid lobectomy is advocated for large cystic
lesions.17,18 In addition, 2 missed cases with multifo-
cal but small PTC foci that might be more difficult to
sample were included in this[2.5-cm group.
In conclusion, the major reason for a false-nega-
tive diagnosis of PTC on FNA is because of inade-
quate tumor sampling due to the mixed nature
of the lesion/heterogeneity of the nodule. This is
illustrated by the RSD between the targeted nodule
and the actual PTC tumor focus in the resection
specimen.
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